Fidelity Investments
GOSS icon

Fidelity Investments’s Gossamer Bio GOSS Stock Holding History

Fidelity Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Buy
130,325
+107,809
+479% +$30.1K ﹤0.01% 4645
2026
Q1 		$7.4K Sell
22,516
-4,215,074
-99% -$6.62M ﹤0.01% 4839
2025
Q4 		$13.1M Buy
4,237,590
+152,244
+4% +$434K ﹤0.01% 1924
2025
Q3 		$10.7M Sell
4,085,346
-3,229,979
-44% -$7.12M ﹤0.01% 1969
2025
Q2 		$9M Sell
7,315,325
-277,655
-4% -$303K ﹤0.01% 1969
2025
Q1 		$8.35M Sell
7,592,980
-340,020
-4% -$393K ﹤0.01% 1984
2024
Q4 		$7.18M Sell
7,933,000
-2,735
-0% -$2.34K ﹤0.01% 2041
2024
Q3 		$7.83M Buy
7,935,735
+5,227
+0.1% +$5.03K ﹤0.01% 2000
2024
Q2 		$7.14M Sell
7,930,508
-258,639
-3% -$193K ﹤0.01% 1968
2024
Q1 		$9.66M Sell
8,189,147
-4,074,771
-33% -$4.49M ﹤0.01% 1876
2023
Q4 		$11.2M Buy
12,263,918
+11,625,497
+1,821% +$8.59M ﹤0.01% 1814
2023
Q3 		$532K Buy
638,421
+634,873
+17,894% +$732K ﹤0.01% 2615
2023
Q2 		$4.26K Buy
3,548
+335
+10% +$417 ﹤0.01% 4407
2023
Q1 		$4.05K Sell
3,213
-53,160
-94% -$102K ﹤0.01% 4444
2022
Q4 		$122K Sell
56,373
-1,230,333
-96% -$10.1M ﹤0.01% 3138
2022
Q3 		$15.4M Buy
1,286,706
+335,700
+35% +$4.17M ﹤0.01% 1703
2022
Q2 		$7.96M Sell
951,006
-262
-0% -$2.03K ﹤0.01% 2078
2022
Q1 		$8.26M Buy
951,268
+56,768
+6% +$547K ﹤0.01% 2193
2021
Q4 		$10.1M Hold
894,500
– – ﹤0.01% 2107
2021
Q3 		$11.2M Buy
+894,500
New +$8.23M ﹤0.01% 2083
2021
Q2 		– Sell
-24,014
Closed -$222K – 4498
2021
Q1 		$222K Hold
24,014
– – ﹤0.01% 2803
2020
Q4 		$232K Sell
24,014
-6,100
-20% -$60.1K ﹤0.01% 2768
2020
Q3 		$374K Sell
30,114
-84,600
-74% -$1.12M ﹤0.01% 2575
2020
Q2 		$1.49M Sell
114,714
-38,300
-25% -$482K ﹤0.01% 2336
2020
Q1 		$1.55M Hold
153,014
– – ﹤0.01% 2244
2019
Q4 		$2.39M Sell
153,014
-891,069
-85% -$17.9M ﹤0.01% 2213
2019
Q3 		$17.5M Hold
1,044,083
– – ﹤0.01% 1620
2019
Q2 		$23.2M Sell
1,044,083
-182,290
-15% -$3.49M ﹤0.01% 1560
2019
Q1 		$26.6M Buy
+1,226,373
New +$25.6M ﹤0.01% 1463

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Fidelity Investments's GOSS Position: Q2 2026 in Review

Fidelity Investments increased its Gossamer Bio (GOSS) stake by 479% in Q2 2026, buying an estimated $30.1K and bringing the position to 130,325 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4645.

Fidelity Investments first reported a position in GOSS in Q1 2019 and has held it in 29 quarters since. The position peaked at $26.6M in Q1 2019. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Fidelity Investments held 130,325 shares of Gossamer Bio worth $21.5K as of Q2 2026.
  • Fidelity Investments bought 107,809 Gossamer Bio shares in Q2 2026, an estimated $30.1K.
  • Gossamer Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4645 holding.
  • Fidelity Investments first reported a position in Gossamer Bio in Q1 2019 and has held it in 29 quarters since.
  • Fidelity Investments's Gossamer Bio position peaked at $26.6M in Q1 2019.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.